Company Information

    Capsida is based in Newbury Park, California, USA. The number of employees in Capsida is unknown. Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic cns and non-cns disorders.

    Here is how Capsida describes itself: "We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications."
      If you are the founder or part of the founding team, please tell the world your story

          Funding & investors

          Capsida has received 3 rounds of venture funding. The total funding amount is around $230M. Last venture funding round was $90M, announced on April, 2021.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors

                  Venture Competitors


                      Share:     facebook    twitter    linkedin    reddit    email

                        Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                        Leave a Reply

                        Your email address will not be published. Required fields are marked *